Trials / Completed
CompletedNCT03080298
Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire
International, Multicenter, Double-blind, Randomized, Placebo-controlled Phase 2a Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 119 (actual)
- Sponsor
- Ivix LLX · Industry
- Sex
- Female
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
This is study of the efficacy, safety and pharmacokinetics of BP101 compared to placebo in patients with a decrease or loss of sexual desire.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BP101 | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-03-14
- Primary completion
- 2017-04-04
- Completion
- 2017-07-25
- First posted
- 2017-03-15
- Last updated
- 2017-08-18
Locations
12 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT03080298. Inclusion in this directory is not an endorsement.